IQVIA Holdings Inc.
Price Chart
Key facts
- Market Cap
- $46.40B
- P/E
- 35.3x
- P/B
- 7.38x
- ROE
- 21.6%
IQVIA Holdings Inc.
IQVIA Holdings Inc. is a leading global provider of technology solutions, advanced analytics, and clinical research services, primarily serving the life sciences and healthcare industries. The company plays a critical role in supporting pharmaceutical, biotechnology, and medical device organizations across the continuum of drug development, from early-stage clinical trials (Phase I–IV) to post-market analysis. IQVIA’s operations are organized into three main segments: Technology & Analytics Solutions, which delivers cloud-based applications, healthcare data management, and consulting; Research & Development Solutions, which offers comprehensive contract research services for clinical trials; and Contract Sales & Medical Solutions, focused on commercial outsourcing and patient engagement. Its vast database covers anonymized health records from over one billion individuals globally, empowering clients to generate real-world evidence and make informed decisions that drive innovation and improve patient outcomes. With a workforce of nearly 90,000 employees in over 100 countries, IQVIA is recognized for its domain expertise, global reach, and role in accelerating healthcare transformation through connected intelligence and next-generation technology.
- CEO
- Mr. Ari Bousbib
- Employees
- 90,000
- Website
- iqvia.com